INTERLEUKIN-1

被引:19
|
作者
DOWER, SK [1 ]
BIRD, TA [1 ]
SIMS, JE [1 ]
机构
[1] IMMUNEX RES & DEV CORP, DEPT MOLEC BIOL, SEATTLE, WA 98101 USA
来源
ADVANCES IN NEUROIMMUNOLOGY | 1992年 / 2卷 / 01期
关键词
D O I
10.1016/S0960-5428(06)80002-1
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
inflammatory processes are controlled by a complex network of interacting regulatory elements including, but not limited to, antigen-specific components of the immune system, cytokines and growth factors, cognate cellular interactions, cell matrix interactions and non-peptide mediators such as prostaglandins. Among these elements, considerable interest has focussed on interleukin 1 (IL-1), to a large extent because this polypeptide mediator was identified early on as a highly pleiotropic molecule that can, by itself, elicit many of the responses associated with acute and chronic inflammatory disease. The advent of molecular biology and modern protein microchemistry has led to a rapid expansion of our understanding of the molecular basis of IL-1 action. At present three species of IL-1 and two types of cell surface IL-1 receptors have been identified and cloned. One of the three species of IL-1 appears to be a pure receptor antagonist. In this chapter the current status of our understanding of the molecular basis of IL-1 action is reviewed.
引用
收藏
页码:1 / 16
页数:16
相关论文
共 50 条
  • [41] Induction of interleukin-1α production in murine Sertoli cells by interleukin-1
    Zeyse, D
    Lunenfeld, E
    Beck, M
    Prinsloo, I
    Huleihel, M
    [J]. BIOLOGY OF REPRODUCTION, 2000, 62 (05) : 1291 - 1296
  • [42] Interleukin-1 and interleukin-1 receptor antagonist in systemic lupus erythematosus
    Chang, DM
    [J]. IMMUNOLOGICAL INVESTIGATIONS, 1997, 26 (5-7) : 649 - 659
  • [43] INTERLEUKIN-1 RECEPTOR ANTAGONIST - EFFECTIVENESS AGAINST INTERLEUKIN-1 FEVER
    COCEANI, F
    LEES, J
    REDFORD, J
    BISHAI, I
    [J]. CANADIAN JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY, 1992, 70 (12) : 1590 - 1596
  • [44] Predictors of interleukin-1β and interleukin-1 receptor antagonist in infant saliva
    Miller, Elizabeth M.
    [J]. AMERICAN JOURNAL OF HUMAN BIOLOGY, 2021, 33 (03)
  • [45] INTERLEUKIN-1 RECEPTOR ANTAGONIST INHIBITS THE HYPERCALCEMIA MEDIATED BY INTERLEUKIN-1
    GUISE, TA
    GARRETT, IR
    BONEWALD, LF
    MUNDY, GR
    [J]. JOURNAL OF BONE AND MINERAL RESEARCH, 1993, 8 (05) : 583 - 587
  • [46] Interleukin-1 and interleukin-1 receptor antagonist in inflammatory bowel disease
    Cominelli, F
    Pizarro, TT
    [J]. ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 1996, 10 : 49 - 53
  • [47] EXPRESSION OF INTERLEUKIN-1 AND INTERLEUKIN-1 RECEPTOR ANTAGONISTS IN ENDOMETRIAL CANCER
    VANLE, L
    HASKILL, S
    JAFFE, GJ
    FOWLER, WC
    [J]. GYNECOLOGIC ONCOLOGY, 1991, 42 (02) : 161 - 164
  • [48] INTERLEUKIN-1 - THE 1ST INTERLEUKIN
    DIGIOVINE, FS
    DUFF, GW
    [J]. IMMUNOLOGY TODAY, 1990, 11 (01): : 13 - 20
  • [49] Interleukin-1β-converting enzyme/caspase-1 in human osteoarthritic tissues -: Localization and role in the maturation of interleukin-1β and interleukin-1β
    Saha, N
    Moldovan, F
    Tardif, G
    Pelletier, JP
    Cloutier, JM
    Martel-Pelletier, J
    [J]. ARTHRITIS AND RHEUMATISM, 1999, 42 (08): : 1577 - 1587
  • [50] Interleukin-1β, Interleukin-1 Receptor Antagonist, and Soluble Interleukin-1 Receptor Type II Secretion in Chronic Fatigue Syndrome
    Joseph G. Cannon
    Jonathan B. Angel
    Leslie W. Abad
    Edouard Vannier
    Maria D. Mileno
    Laura Fagioli
    Sheldon M. Wolff
    Anthony L. Komaroff
    [J]. Journal of Clinical Immunology, 1997, 17 : 253 - 261